Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis


KORKMAZ T., Seber S., KEFELI U., SARI E., Canhoroz M., OVEN B., ...More

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.15, no.7, pp.535-540, 2013 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 7
  • Publication Date: 2013
  • Doi Number: 10.1007/s12094-012-0960-6
  • Title of Journal : CLINICAL & TRANSLATIONAL ONCOLOGY
  • Page Numbers: pp.535-540

Abstract

Small cell lung cancer (SCLC) has a high relapse rate despite being very chemosensitive. The efficacy of second-line treatment is dismal. Our aim was to evaluate the outcome of second-line treatment.